S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom
S&P 500   5,022.21
DOW   37,753.31
QQQ   425.84
ASML Fires Warning Shot For Tech Investors
Checking in with 5 Bitcoin Stocks Ahead of Bitcoin's Halving
Closing prices for crude oil, gold and other commodities
Lululemon’s P/E Is Back to 2017 Levels: Should You Buy the Dip?
Stock market today: Wall Street dips to send S&P 500 to its longest losing streak since January
Abbott Laboratories Outlook is Healthy: Buy the Dip
Prologis Stock Leading U.S. Logistics Boom

Lantheus (LNTH) Earnings Date, Estimates & Call Transcripts

$61.48
-0.25 (-0.40%)
(As of 04/17/2024 ET)

Earnings Summary

Upcoming
Earnings Date
May. 2Estimated
Actual EPS
(Feb. 22)
$1.59 Beat By $0.26
Consensus EPS
(Feb. 22)
$1.33
Skip Charts & View Estimated and Actual Earnings Data

LNTH Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

LNTH Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Lantheus Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage EstimateCompany Guidance
Q1 20243$1.05$1.38$1.261.500 - 1.540
Q2 20243$1.17$1.44$1.32 
Q3 20243$1.10$1.44$1.29 
Q4 20243$1.16$1.48$1.34 
FY 202412$4.48$5.74 $5.22

LNTH Earnings Date and Information

Lantheus last issued its earnings results on February 22nd, 2024. The medical equipment provider reported $1.59 earnings per share for the quarter, topping the consensus estimate of $1.33 by $0.26. The business earned $354 million during the quarter, compared to analyst estimates of $350.44 million. Lantheus has generated $4.64 earnings per share over the last year ($4.64 diluted earnings per share) and currently has a price-to-earnings ratio of 13.3. Earnings for Lantheus are expected to decrease by -3.67% in the coming year, from $5.72 to $5.51 per share. Lantheus has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off prior year's report dates.

Lantheus Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript
5/2/2024
Estimated)
------- 
2/22/2024Q4 2023$1.33$1.59+$0.26$1.71$350.44 million$354.00 million
11/2/2023Q3 2023$1.19$1.29+$0.10$0.70$315.01 million$319.95 million
8/3/2023Q2 2023$1.23$1.40+$0.17$1.47$306.48 million$321.70 million
5/4/2023Q1 2023$1.21$1.37+$0.16$2.78$280.65 million$300.78 million
2/23/2023Q4 2022$0.87$1.28+$0.41$4.30$244.61 million$263.17 million
11/3/2022Q3 2022$0.75$0.90+$0.15$0.94$228.52 million$239.29 million  
8/4/2022Q2 2022$0.64$0.81+$0.17$1.01$204.51 million$223.80 million  
4/29/2022Q1 2022$0.41$0.97+$0.56$1.33$165.30 million$208.90 million    
2/24/2022Q4 2021$0.17$0.25+$0.08$1.09$111.77 million$129.60 million    
11/4/2021Q3 2021$0.06$0.08+$0.02$0.36$97.13 million$102.10 million    
7/28/2021Q2 2021$0.05$0.11+$0.06$0.61$94.60 million$101.06 million    
5/4/2021Q1 2021($0.01)$0.05+$0.06($0.03)$87.24 million$92.51 million  

Lantheus Earnings - Frequently Asked Questions

When is Lantheus's earnings date?

Lantheus has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, May 2nd, 2024 based off last year's report dates. Learn more on LNTH's earnings history.

Did Lantheus beat their earnings estimates last quarter?

In the previous quarter, Lantheus (NASDAQ:LNTH) reported $1.59 earnings per share (EPS) to beat the analysts' consensus estimate of $1.33 by $0.26. Learn more on analysts' earnings estimate vs. LNTH's actual earnings.

How much revenue does Lantheus generate each year?

Lantheus (NASDAQ:LNTH) has a recorded annual revenue of $1.30 billion.

How much profit does Lantheus generate each year?

Lantheus (NASDAQ:LNTH) has a recorded net income of $326.66 million. LNTH has generated $4.64 earnings per share over the last four quarters.

What is Lantheus's price-to-earnings ratio?

Lantheus (NASDAQ:LNTH) has a trailing price-to-earnings ratio of 13.25 and a forward price-to-earnings ratio of 10.75.

What is Lantheus's EPS forecast for next year?

Lantheus's earnings are expected to decrease from $5.72 per share to $5.51 per share in the next year, which is a -3.67% change.


More Earnings Resources from MarketBeat

This page (NASDAQ:LNTH) was last updated on 4/17/2024 by MarketBeat.com Staff

From Our Partners